Transient receptor potential vanilloid receptor 1 (TRPV1) is a non-selective cation channel that is stimulated by heat (>43 °C), mechanical/osmotic stimuli, and low pH. The importance of TRPV1 in inflammatory responses has been demonstrated, whereas its participation in brains remains unclear. In the present study, the intracerebroventricular (icv) administration of the TRPV1 agonist resiniferatoxin (RTX) induced the activation of signal transducer and activator of transcription 3 (STAT3) in circumventricular organs (CVOs) and thermoregulation-associated brain regions with a similar patttern to the peripheral and icv administration of lipopolysaccharide (LPS). With the peripheral and icv LPS stimuli, STAT3 activation was significantly lower in Trpv1−/− mice than in Trpv1+/+ mice. The icv administration of RTX induced transient hypothermia, whereas that of the TRPV1 antagonist capsazepine enhanced the magnitude and period of LPS-induced hyperthermia. These results indicate that TRPV1 is important for activating proinflammatory STAT3 signaling and thermoregulation-associated brain pathways in the brain.
Transient receptor potential vanilloid 1 (TRPV1) is a non-selective cation channel with a preference for Ca2+ and is activated by heat, mechanical/osmotic stimuli, protons, and pH < 5.91,2. TRPV1 is strongly expressed in the terminals of the dorsal root ganglion and trigeminal ganglion and in some peptidergic sensory neurons in the nodose ganglion1,2. These TRPV1-expressing sensory neurons innervate the skin and visceral organs and have nociceptive or pain functions through the activation of the primary afferent fibers innervating them3,4.
TRPV1 is activated by the plant-derived lipophilic substances capsaicin and resiniferatoxin (RTX), which show structural similarities to the endogenous TRPV1 agonists of fatty acid derivatives5,6,7. The peripheral administration of the TRPV1 agonists capsaicin, RTX, rinvanil, and arvanil has been shown to induce severe hypothermia associated with skin vasodilatation8,9,10,11,12; however, this did not occur in Trpv1−/− mice13. Hot peppers have been used in diets and medicinal treatments worldwide in order to reduce body temperature14. Capsaicin crosses the blood-brain barrier (BBB)15 and the dose needed to induce hypothermia is at least 25-fold higher for peripheral administration (~5 μg)16 than for central administration (200 ng)17. Moreover, the intracerebroventricular (icv) administration of the TRPV1 agonists capsaicin8,9, RTX18, and arvanil19 has been shown to induce transient hypothermia. Therefore, capsaicin is assumed to act on thermoregulation-associated brain regions to cause hypothermia20,21; however, the mechanisms responsible for the effects of TRPV1 agonists in the brain remain unknown.
The peripheral administration of various TRPV1 antagonists causes hyperthermia with tail skin vasoconstriction and/or the activation of thermogenesis10,13. However, previous studies reported that the icv administration of TRPV1 antagonists failed to induce hyperthermia under normal conditions13,22. Trpv1−/− mice showed similar increases in body temperature against standard heat loading, but exhibited a higher amplitude for the daily body temperature rhythm23. TRPV1 antagonists may cause hyperthermia by disrupting the peripheral suppression mechanisms of hyperthermia5,10,23. This effect precludes the development of TRPV1 antagonists, widely regarded as next-generation pain therapeutics7,10.
Sensory circumventricular organs (CVOs) include the organum vasculosum of the lamina terminalis (OVLT), subfornical organ (SFO), and area postrema (AP). They have high vascular permeability due to the lack of the BBB at endothelial tight junctions, are considered to act as the main entry route of blood-derived inflammatory cytokines and pathogens24,25,26, and convey their information into inflammatory and thermoregulatory brains regions27,28. In sensory CVOs, glial fibrillary acidic protein (GFAP)-expressing multipotent neural stem cells (NSCs) express TRPV1 and NaX that sense and control body fluid homeostasis25,29. The expression levels of Toll-like receptor 4 (TLR4) and its co-receptor CD14 were found to be markedly higher in sensory CVOs than in other brain regions30,31,32. The peripheral and central administration of lipopolysaccharide (LPS) was recently shown to stimulate TLR4 on the multipotent NSCs of sensory CVOs, which resulted in faster proinflammatory responses such as the activation of JAK-signal transducer and activator of transcription 3 (STAT3) and nuclear factor-κB (NF-κB) in CVOs than in other brain regions27,33,34. These findings strongly suggest that blood-derived LPS and cytokines initially reach CVOs, which lack the BBB, and induce the early phase of inflammatory responses; information is then transferred to adjacent thermoregulatory brain regions27,35.
However, progress in understanding the potential involvement of TRPV1 in inflammatory and thermoregulatory responses in the brain has been limited. Therefore, we herein used genetically modified mice and pharmacological tools to determine the contribution of TRPV1 in the brain to inflammatory and thermoregulatory actions. Our results demonstrated that LPS-induced STAT3 activation was deficient in Trpv1−/− mice and also that the TRPV1 agonist RTX activates STAT3 in sensory CVOs and thermoregulatory hypothalamic regions. The TRPV1 agonist RTX tonically induced hypothermia in a dose-dependent manner under normal conditions, while the TRPV1 antagonist capsazepine augmented the magnitude and period of LPS-induced hyperthermia. These results indicate that TRPV1 in the brain is inactive under normal conditions, but is activated under inflammatory conditions, and the TRPV1 signaling cascade activates proinflammatory STAT3 signaling and endogenous antipyretic thermoregulatory pathways.
Deficiency in brain STAT3 activation in Trpv1 −/− mice during inflammation
We determined whether TRPV1 plays a role in inflammatory signaling cascades in the brain. STAT3 is a well-known marker of proinflammatory responses in the brain27,34. The activation of STAT3 may be detected by the phosphorylation of STAT3 and its subsequent nuclear translocation36. We previously demonstrated that GFAP+ multipotent NSCs in sensory CVOs expressed TRPV1 and TLR425,29,32 and also revealed the activation of STAT3 following an LPS-induced inflammatory stimulation. STAT3 activation occurred in GFAP+ NSCs in sensory CVOs and GFAP+ astrocytes in thermoregulatory hypothalamic subregions such as the median preoptic nucleus (MnPO) and preoptic area (POA) in Trpv1+/+ mice after the peripheral administration of 50 μg/kg LPS (Fig. 1a). The intraperitoneal administration of LPS has been shown to induce hyperthermia at doses of 10~100 μg/kg in mice37. STAT3 activation is reportedly absent in unstimulated control mice (data not shown)32. STAT3 signaling activation has also been detected in the ventral hippocampal commissure (vhc), median eminence (ME), arcuate nucleus (Arc), supraoptic nucleus (SON), and solitary nucleus (Sol) in Trpv1+/+ mice (Fig. 1a and Fig. S1a–d). In contrast to Trpv1+/+ mice, prominent STAT3 activation was hardly detected in any brain region including sensory CVOs and thermoregulatory brain subregions in Trpv1−/− mice after the peripheral administration of LPS (Fig. 1b and Fig. S1e–h). The peripheral administration of 50 μg/kg LPS clearly increased the number of STAT3+ GFAP+ NSCs in sensory CVOs (P < 0.001) and STAT3+ GFAP+ astrocytes in the MnPO and POA (P < 0.05) in Trpv1+/+ mice more than that of the control (Fig. 1c). However, the number of STAT3+ GFAP+ NSCs and astrocytes in these brain regions in Trpv1−/− mice was not significantly affected by the peripheral administration of LPS (P > 0.05).
In order to clarify whether the deficiency in LPS-induced STAT3 activation in the Trpv1−/− mouse is due to a dysfunction in TRPV1 in the brain rather than in the periphery, we examined the effects of the icv administration of LPS on STAT3 activation in the brain. The icv administration of 30 ng/kg LPS strongly induced the activation of STAT3 in GFAP+ NSCs in sensory CVOs and GFAP+ astrcoytes in the hypothalamic and medulla subregions in Trpv1+/+ mice, similar to the peripheral administration (Fig. 2a and Fig. S2). However, STAT3 activation was scarcely observed in Trpv1−/− mice after the icv administration of LPS (Fig. 2b). No significant differences were observed in the number of STAT3+ GFAP+ NSCs and astrocytes in Trpv1−/− mice between the icv administration of LPS and the vehicle control (Fig. 2c). The brain subregions in which STAT3 activation occurred in GFAP+ cells were similar following the peripheral and icv administration of LPS (Table 1). Taken together, these results indicate that TRPV1 is necessary for activating STAT3 in the brain under LPS-induced inflammatory conditions.
Activation of STAT3 by TRPV1
TRPV1 activation in the brain by the TRPV1 agonists capsaicin8,9, RTX18, and arvanil19 is known to induce transient hypothermia; however, the mechanisms by which the activation of TRPV1 in the brain causes hypothermia, particularly the TRPV1-responsive brain subregions, cellular phenotypes, and signaling pathways, currently remain unclear. The icv administration of the TRPV1 agonist RTX more strongly induced STAT3 activation in sensory CVOs and thermoregulatory hypothalamic subregions at a dose of 500 ng/kg (Fig. 3b) than the vehicle (Fig. 3a). Double labeling immunohistochemistry showed that STAT3 activation occurred in GFAP+ NSCs in sensory CVOs and GFAP+ astrocytes in thermoregulatory hypothalamic subregions in Trpv1+/+ mice (Fig. 3c). RTX also activated STAT3 in GFAP+ astrocytes in the vhc, ME, Arc, and Sol in Trpv1+/+ mice (Fig. S3a–d). It is important to note that the brain subregions in which RTX-induced STAT3 activation occurred in GFAP+ cells were similar to those following the peripheral and icv administration of LPS (Table 1). STAT3 activation was never detected in sensory CVOs or thermoregulatory hypothalamic subregions in Trpv1−/− mice after the icv administration of 500 ng/kg RTX (Fig. 3d). The results of the quantitative analysis showed that the icv administration of 500 ng/kg RTX significantly increased the number of STAT3+ GFAP+ cells in Trpv1+/+ mice (P < 0.001), while that of 125 and 250 ng/kg RTX slightly increased this number, except for in the OVLT (P > 0.05, Fig. 4a). The icv administration of 500 ng/kg RTX slightly increased the number of STAT3+ HuC/D+ neurons (Fig. 4b and Fig. S4).
NF-kB is the main downstream signaling pathway of the LPS receptor TLR4 and, thus, is often used as a marker of proinflammatory responses38. The icv administration of 500 ng/kg RTX did not induce the activation or nuclear translocation of NF-kB, whereas the peripheral administration of 50 μg/kg LPS induced NF-kB activation in sensory CVOs and thermoregulatory hypothalamic subregions (Fig. S5). Collectively, these results indicate that the TRPV1 signal cascade leads to the activation of STAT3 in GFAP+ cells in sensory CVOs and thermoregulatory hypothalamic regions in the brain.
TRPV1-dependent control of body temperature
We next investigated whether TRPV1 in the brain participates in controlling body temperature under normal and inflammatory conditions. We monitored core body temperature in response to pharmacological treatments in mice fitted with a G2 E-mitter. All animals initially showed stress fever as a consequence of handling during/after the administration procedure regardless of whether LPS or saline was given. The icv administration of 0.9% saline induced a transient increase in core body temperature of approximately 1.50 ± 0.60 °C at 20 min, which soon decreased to the initial body temperature. The icv administration of 250 and 500 ng/kg, but not 125 ng/kg, to Trpv1+/+ mice decreased body temperature at 35–45 min (P < 0.05 vs vehicle) with a nadir (−1.38 ± 0.94 °C) at 50 min and 25–140 min (P < 0.05 vs vehicle) with a nadir (−2.79 ± 0.28 °C) at 45 min (Fig. 5a). However, the icv administration of 500 ng/kg RTX to Trpv1−/− mice induced stress-associated hyperthermia similar to the saline vehicle control, without a subsequent decrease in body temperature (P > 0.05). These results indicate that the activation of TRPV1 by RTX in the brain induces transient hypothermia in a dose-dependent manner under normal conditions.
We then examined the effects of the TRPV1 antagonist capsazepine and agonist RTX on body temperature under LPS-induced inflammatory conditions (Fig. 5b). The icv administration of the TRPV1 antagonist capsazepine at a dose of 100 μg/kg and agonist RTX at a dose of 500 ng/kg to Trpv1+/+ mice was performed 30 min after the intraperitoneal administration of 50 μg/kg LPS. The peripheral administration of LPS elevated body temperatures in Trpv1+/+ mice at 70–140, 165–185, 215–230, and 245–255 min (P < 0.05 vs saline-vehicle) with a peak (1.45 ± 0.17 °C) at 80 min. The icv administration of the TRPV1 antagonist capsazepine significantly promoted LPS-induced hyperthermia at 45–75 and 85–330 min (P < 0.05 vs LPS-vehicle) with a peak (2.35 ± 0.13 °C) at 160 min; however, the administration of capsazepine alone did not have any significant effects on body temperature (P > 0.05 vs saline-vehicle). The icv administration of RTX 500 ng/kg decreased body temperature at 60–235 min (P < 0.05 vs saline-vehicle) with the nadir (−2.63 ± 0.56 °C) at 90 min. However, the RTX-induced decrease in body temperature was significantly larger at 145–330 min in LPS-treated mice (nadir; −3.89 ± 0.91 °C at 115 min, P < 0.05) than in vehicle-treated animals (saline-RTX). Taken together, these results indicate that TRPV1 exerts endogenous antipyretic effects during LPS-induced inflammation.
The mechanisms responsible for the thermoregulatory and inflammatory roles of TRPV1 have been a study subject for the last several decades; however, information regarding these roles in the brain is limited. A large number of studies have demonstrated the peripheral contribution of TRPV1 to thermoregulatory and inflammatory responses. In peripheral tissues, TRPV1 may be continuously activated and act as a suppressor of hyperthermia in order to maintain homeothermy, and, thus, its inactivation by TRPV1 antagonists results in hyperthermia5,10,23. However, the icv administration of TRPV1 antagonists had no effect on body temperature under normal conditions10,13,22. Therefore, hyperthermia induced by TRPV1 antagonists may be due to the inhibition of the TRPV1 signaling cascade in peripheral tissues5. In the present study, the icv administration of the TRPV1 agonist RTX induced transient hypothermia under normal conditions, which is consistent with previous findings on capsaicin8,9, RTX18, and arvanil19. In the present study, we found that the icv administration of the TRPV1 antagonist capsazepine enhanced the period and magnitude of LPS-induced hyperthermia. Moreover, RTX-induced hypothermia was augmented when combined with the peripheral administration of LPS. Taken together, TRPV1 in the brain appears to be activated under inflammaotry conditons only and acts as an endogenous antipyretic factor to suppress aberrant hyperthemia in homeotherms.
Proinflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and IL-6 promote the sensitization of TRPV1 in dorsal root ganglion neurons and are involved in the development and maintenance of neuropathic pain39. Proinflammatory cytokine levels in serum and the brain were found to be elevated after the peripheral administration of LPS40. TNF-α rapidly sensitizes TRPV1 activity and enhances Ca2+ influx induced by capsaicin in pulmonary sensory neurons41. The levels of the endogenous TRPV1 agonist anandamine in the brain and peripheral tissues were found to be elevated after the peripheral administration of LPS42,43. Thus, elevations in various cytokines and endogenous agonists may be factors activating TRPV1 in the brain under inflammatory conditions.
We previously revealed that the activation of proinflammatory STAT3 was absent in Trpv1−/− mouse brains after the peripheral and icv administration of LPS. The present study showed that the icv administration of the TRPV1 agonist RTX induced the activation of STAT3 under normal conditions. TRPV1 functions in the activation and acquisition of the inflammatory properties of T cells by controlling the T cell receptor signaling complex44. The activation of TRPV1 also stimulates extracellular-signal-regulated, c-Jun N-terminal, and p38 mitogen-activated protein kinases and releases the cytokines IL-6 and -8 in a manner that is dependent on extracellular Ca2+ levels in dental pulp45 and corneal epithelial cells46. STAT3 is known to be activated by IL-6 and several growth factors36. In contrast, the present study revealed that the icv administration of RTX did not activate proinflammatory NF-κB signaling; however, it was activated in the brain after the administration of LPS30,34,36. A previous study reported that the sensitization of TRPV1 was mediated by TLR4 signaling during treatments and chronic persistent pain in paclitaxel chemotherapy47. Recent studies have demonstrated that TRPV1 and TLR4 are expressed by GFAP+ NSCs25,32. However, capsaicin has been shown to inhibit NF-κB activation in macrophages, myelomonoblastic leukemic cells, and dental pulp cells45,48. Thus, the activation of TRPV1 signaling cascades leads to the activation of proinflammatory STAT3 signaling in the brain under inflammatory conditions.
In the present study, the icv administration of the TRPV1 antagonist capsazepine enhanced the period and magnitude of LPS-induced hyperthermic responses. STAT3 is known to be involved in the transcription of several cytokines in order to maintain brain inflammation36. In addition to traditional transcription control, STAT3 regulates cell metabolism by suppressing complexes I and II in mitochondria49. The inhibition of mitochondrial STAT3 activation results in reductions in mitochondrial oxidative phosphorylation and cell exocytosis50. The icv administration of the STAT3 inhibitor AG490 has been shown to exaggerate LPS-induced hyperthermia, but abrogate LPS-induced reductions in locomotor activity51, indicating a dissociation between fever and other components of sickness behavior. Thus, the TRPV1-induced activation of STAT3 signaling may be concerned with inflammatory and thermoregulatory responses during inflammation.
The icv administration of the TRPV1 agonist RTX prominently activated STAT3 in sensory CVOs and moderately activated thermoregulatory hypothalamic regions. The peripheral administration of LPS induced STAT3 activation in GFAP+ NSCs in sensory CVOs and GFAP+ astrocytes in other brain regions32,34. Brain cells are equipped with mechanisms that directly detect blood-derived information in sensory CVOs24,52. The stronger expression of Tlr4 mRNA has been detected in sensory CVOs30,31 than in other brain regions, and TLR4 is specifically expressed at GFAP+ NSCs32. In our previous study, TRPV1 was found to be specifically expressed at GFAP+ NSCs and the icv administration of RTX induced Fos in GFAP+ NSCs in sensory CVOs25,32. The maintenance of a constant body temperature by homeotherms largely depends on body fluid homeostasis53, and TRPV1 is activated by hyperosmolarity2. Thus, the results of the present study demonstrated that the TRPV1-dependent STAT3 signaling pathways of the brain were similar to those activated by the peripheral and icv administration of LPS, indicating the importance of TRPV1 signaling in LPS-induced thermoregulatory and inflammatory pathways in the brain.
Previous studies showed that the treatment of neonatal rodents with capsaicin induced brain changes including thinner cortices and increased neuronal density, reminiscent of those reported in schizophrenia54,55. Brain inflammation induced in neonatal rodents by an injection of LPS or the peripheral administration of E. coli elicits schizophrenia-like behavior and structural brain damage in adulthood56. Thus, the results of the present study indicate that the ingestion of an excessive amount of capsaicin from food causes brain inflammation and subsequent damage in humans, particularly the young.
Adult male C57BL/6J strain WT and TRPV1 KO mice (70–105 days old) were housed in a colony room with a 12-h light/dark cycle and given ad libitum access to commercial chow and tap water. TRPV1 KO mice were obtained from Dr. D. Julius, University of California, San Francisco, CA3. All experiments were performed in accordance with the Guidelines laid down by the NIH and Proper Conduct of Animal Experiments Science Council of Japan. The experimental protocol was approved by the Animal Ethics Experimental Committee of the Kyoto Institute of Technology.
Administration of LPS and the TRPV1 agonist and antagonist
Stock solutions of RTX (0.7 mg/ml; Carbosynth, Berkshire, UK) and capsazepine (10 mg/ml; Wako pure chemical, Osaka, Japan) were dissolved in 100% ethanol and stored at −80 °C. The stock solutions of RTX and capsazepine were diluted with vehicle solution consisting of pyrogen-free physiological saline (Otsuka Pharmaceutical Co. LTD., Tokushima, Japan) containing 10% Tween 80 and 10% ethanol prior to use. The stock solution of LPS (1 mg/ml; Sigma-Aldrich, 055: type B5) was dissolved in pyrogen-free physiological saline (Otsuka Pharmaceutical Co. LTD.), stored at −80 °C, and diluted with physiological saline prior to use.
In the icv administration protocol, a stainless steel cannula (25-gauge) was implanted in each mouse under anesthesia with chloral hydrate so that its tip laid in the lateral cerebral ventricle (0.3 mm anteroposterior and 1.0 mm lateral to the bregma and 2.5 mm dorsoventral below the skull) using a standard stereotaxic technique (Paxinos and Franklin, 2007). Freely moving mice received the icv administration of RTX (1.25, 2.5, or 5 μg/ml), capsazepine (1 mg/ml), LPS (300 ng/ml), the vehicle solution, and physiological saline using a Model EP-1000E infusion pump (3 μl, 0.5 μl/min, Melquest, Toyama, Japan). Regarding the peripheral LPS stimulation, mice received a single intraperitoneal administration of LPS (5 μg/ml, 0.3 ml).
After deep anesthesia with urethane, mice were perfused with PBS (pH 7.4) containing 5 U/ml heparin followed by 4% PFA in 0.1 M PB (pH 7.4). Fixed brains were cryoprotected by 30% sucrose in PBS (pH 7.4) and frozen quickly in Tissue-Tek OCT compound (Sakura Finetechnical, Tokyo, Japan). Sections were obtained by a coronal cut on a cryostat (Leica, Wetzlar, Germany) at a thickness of 30 μm. In single and double immunofluorescent staining, a standard technique was performed on free-floating sections as described in our previous study. In brief, sections were washed with PBS and treated with 25 mM glycine in PBS for 20 min to quench the remaining fixative aldehyde. Sections were preincubated with 5% normal goat serum in PBS containing 0.3% Triton X-100 (PBST) at 4 °C for 24 h and then incubated with the primary antibody in PBST containing 1% ngS at 4 °C for 72 h. The following primary antibodies were used: a mouse monoclonal antibody against HuC/D (Molecular Probes, dilution 1:400); guinea pig antibody against GFAP (dilution 1:500)32; rabbit polyclonal antibody against NF-kB p65 (C-20, Santa Cruz Biotechnology, dilution 1,000) and STAT3 (Cell Signaling, dilution 1:2,000). After several washes with PBST, they were further incubated with an Alexa 488- or 594-conjugated secondary goat antibody (Jackson ImmunoResearch, dilution 1:400).
Confocal observation and quantification
In the confocal microscopic observations, coverslips were sealed with Vectashield (Vector Labs, Burlingame, CA) and observations were performed using a laser-scanning confocal microscope (LSM-510, Carl Zeiss). We selected at least 5 sections per animal from the OVLT (between bregma 0.50 and 0.62 mm) and 7 sections per animal from the MnPO (between the bregma 0.14 and 0.38 mm), POA (between the bregma 0.14 and −0.10 mm), SFO (between the bregma −0.58 and −0.82 mm), and AP and Sol (between the bregma −7.48 and −7.64 mm) according to the mouse brain atlas57. In order to perform a quantitative analysis, confocal images were obtained under the same pinhole size, brightness, and contrast setting. We saved images (1,024× 1,024 pixels) as TIF files by employing the Zeiss LSM image browser for Windows and arranged them using Photoshop CC. In quantitative analyses, the total area of the OVLT, SFO, and AP was measured using WinRoof, an image analyzing system (Mitani Corporation, Fukui, Japan). The numbers of STAT3- and NF-kB-positive nuclei in GFAP-labeled astrocytes and HuC/D-labeled neurons were counted using WinRoof, the threshold intensity of which was set to include measurement profiles by visual inspections and was kept constant. An analysis of all images was performed such that the experimenter was blind to the treatment group. Differences from the vehicle were assessed using a significance level of P < 0.05 (Student’s t-test).
Measurement of body temperature
Mice were anesthetized with chloral hydrate, implanted intraperitoneally with a transponder (G2 E-mitter) that recorded core body temperature, and were then housed at an ambient temperature of 25 °C under a 12-h light/dark cycle (lights on at 7:00 A.M.). Mice were kept for at least 1 week after the implantation of the telemeter. The administration of RTX and LPS was performed between 11.00 h and 12.00 h. Abdominal temperature and gross locomotor activity were measured by biotelemetry at 5-min intervals and plotted at 10-min intervals over a period of 60 min before and 360 min after the treatment. Data were acquired and fed to a computer using Vital View software (VitalView series 4000).
How to cite this article: Yoshida, A. et al. TRPV1 is crucial for proinflammatory STAT3 signaling and thermoregulation-associated pathways in the brain during inflammation. Sci. Rep. 6, 26088; doi: 10.1038/srep26088 (2016).
This work was supported in part by Scientific Research Grants from the Japan Society for the Promotion of Science (16K07027), Salt Science (1555), Sasagawa Scientific Research Grant from The Japan Science Society (27-403), Research Fellowship of the Japan Society for the Promotion of Science for Young Scientists (16J10225), and the Cooperative Study Program of National Institute for Physiological Sciences (125 and 127).
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/